Jones Financial Companies
HUMA icon

Jones Financial Companies’s Humacyte HUMA Stock Holding History

Jones Financial Companies’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9K Buy
16,870
+363
+2% +$336 ﹤0.01% 3725
2026
Q1 		$11.1K Buy
16,507
+3,755
+29% +$3.9K ﹤0.01% 3542
2025
Q4 		$12.2K Sell
12,752
-7,093
-36% -$10K ﹤0.01% 3132
2025
Q3 		$34.3K Buy
19,845
+700
+4% +$1.37K ﹤0.01% 2534
2025
Q2 		$40.6K Buy
19,145
+10,392
+119% +$20K ﹤0.01% 2308
2025
Q1 		$17.2K Buy
8,753
+6,953
+386% +$26.1K ﹤0.01% 2494
2024
Q4 		$9.09K Sell
1,800
-9,666
-84% -$47.8K ﹤0.01% 2563
2024
Q3 		$64K Buy
11,466
+300
+3% +$1.98K ﹤0.01% 1553
2024
Q2 		$53.6K Buy
+11,166
New +$58.1K ﹤0.01% 1232

Other funds holding HUMA

Antipodes Partners
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Davidson Kempner Capital Management
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jones Financial Companies's HUMA Position: Q2 2026 in Review

Jones Financial Companies increased its Humacyte (HUMA) stake by 2.2% in Q2 2026, buying an estimated $336 and bringing the position to 16,870 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3725.

Jones Financial Companies first reported a position in HUMA in Q2 2024 and has held it in 9 quarters since. The position peaked at $64K in Q3 2024. 164 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Jones Financial Companies held 16,870 shares of Humacyte worth $11.9K as of Q2 2026.
  • Jones Financial Companies bought 363 Humacyte shares in Q2 2026, an estimated $336.
  • Humacyte made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3725 holding.
  • Jones Financial Companies first reported a position in Humacyte in Q2 2024 and has held it in 9 quarters since.
  • Jones Financial Companies's Humacyte position peaked at $64K in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.